Untitled Page
Main Menu
Home > Equity > News Analysis > Hot Pursuit
27 September 2020

Hot Pursuit

Prev Next
26-Sep-2020 (17:56)
Reliance Retail receives Rs 7,500 cr from Silver Lake for 1.75% stake
26-Sep-2020 (16:32)
Indoco Remedies launches COVID treatment drug
26-Sep-2020 (15:30)
Dr Reddys Labs launches Tecfidera generic in US market
Dr. Reddy's Dimethyl Fumarate delayed-release capsules are available in 120 mg and 240 mg capsules in bottle count sizes of 14 and 60 capsules, respectively. The drug is used to treat adults with various forms of multiple sclerosis.

The Tecfidera brand and generic market had US sales of approximately $3.8 billion MAT for the most recent twelve months ending in June 2020 according to IQVIA Health.

Shares of the drug major closed 1.78% higher at Rs 5114.05 on Friday. In the past one month, the stock has gained 15.56% compared with 0.83% rise in Nifty Pharma index.

Dr. Reddy's Laboratories is an integrated pharmaceutical company. Its consolidated net profit skid 12.11% to Rs 594.60 crore on 14.93% jump in revenue from operations to Rs 4,417.50 crore in Q1 June 2020 over Q1 June 2019.


26-Sep-2020 (14:19)
SBI board to mull fund raising
26-Sep-2020 (14:03)
US stocks gain as tech shares bounce
26-Sep-2020 (13:40)
NALCO, NRL sign long-term pact for supply of CP Coke
26-Sep-2020 (12:55)
LIC hikes stake in Grasim Inds
26-Sep-2020 (11:54)
NCL Inds terminates agreement with Chinese firm
26-Sep-2020 (11:00)
Central Bank of India closes Rs 255 crore QIP
26-Sep-2020 (10:00)
JSW Energy unit gets order from Solar Energy Corp
Toll Free number: 1800-425-5501 / 1800-103-5501